Related Experiment Video

Updated: Jun 1, 2026

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

G protein-coupled receptor kinases in normal and failing myocardium

Zheng Maggie Huang1, Jessica I Gold, Walter J Koch

  • 1Center for Translational Medicine and George Zallie and Family Laboratory for Cardiovascular Gene Therapy, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.

Frontiers in Bioscience (Landmark Edition)
|May 31, 2011
PubMed

Insights

Heart failure involves desensitization of G protein-coupled receptor (GPCR) signaling, particularly beta-adrenergic receptors (betaARs). GPCR kinases (GRKs) like GRK2 and GRK5 contribute to this, impacting cardiac function.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Heart failure (HF) is a major cause of death, characterized by desensitization of G protein-coupled receptor (GPCR) signaling.
  • Beta-adrenergic receptor (betaAR) desensitization is a hallmark of HF, impairing cardiac function.

Purpose of the Study:

  • To review the role of GPCR kinases (GRKs) in HF pathogenesis.
  • To discuss the canonical and non-canonical functions of GRKs in the failing heart.
  • To explore GRKs as potential therapeutic targets for HF.

Main Methods:

  • Review of existing literature on GRK function in cardiac physiology and pathophysiology.
  • Analysis of the role of GRK2 and GRK5 in GPCR desensitization and non-GPCR signaling pathways.
  • Discussion of the implications for HF treatment.

Main Results:

  • GRK2 and GRK5 are upregulated in HF, contributing to betaAR desensitization and loss of cardiac function.
  • GRKs possess novel non-GPCR kinase activities that may influence cardiac hypertrophy and HF.
  • GRK-mediated signaling pathways are critical in the progression of cardiac disease.

Conclusions:

  • GRKs play a significant role in the development and progression of heart failure.
  • Targeting GRKs offers a promising strategy for novel HF therapies.
  • Further research into GRK non-GPCR functions is warranted for a comprehensive understanding of cardiac disease.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...